NEW YORK, NY – Everyday Health, Inc.’s site for healthcare professionals, MedPage Today, furthers its leadership position as a top resource for physicians and today announces an exclusive partnership with CollabRx, Inc., a leader in expert systems to inform healthcare decisions, making MedPage Today the exclusive website for Oncology Next. Powered by CollabRx, Oncology Next is a cloud-based genomic decision support solution accessing knowledge from the world’s oncology thought leaders. The tool enables physicians to more accurately provide patient-specific treatment by taking into account a tumor’s genetic profile to determine the best possible treatment plan with targeted therapies. Oncology Next will be available for melanoma, colorectal cancer, breast cancer and lung cancer as a free service on a rolling basis starting with lung cancer on August 8, 2012 at MedPageToday.com/Oncology-Next.
The explosion of tumor genetic data has led to a rise in the development of cancer therapies that target specific genetic profiles. Oncology Next aggregates the vast, segmented expert knowledge base on targeted cancer therapy options and clinical trials searchable by the genomic information for a given patient’s tumor. Everyday Health and MedPage Today will also offer exclusive sponsorships and lead generation tools to major healthcare companies.
Oncology Next tools serve as a user interface to the proprietary CollabRx knowledge base that examines the relationship between tumor genetic profiles, disease stage and prior treatments, and therapy considerations including molecular diagnostics, medical tests, clinical trials, drugs, biologics and other information relevant for cancer treatment planning. The CollabRx knowledge base is updated regularly to reflect the continual release of relevant information into the public domain.
The partnership allows Medpage Today to further its position as the leading resource for healthcare professionals and expand its offerings for oncologists by offering this important biomarker testing and genomic-based cancer treatment tool. MedPage Today reaches 96% of all oncologists.
“MedPage Today’s partnership with CollabRx illustrates our commitment to providing innovative and state-of-the-art tools for physicians,” explained Ben Wolin, CEO and Co-Founder Everyday Health, Inc. “Oncology Next provides the community of oncologists free access to medical and scientific advances in genomic medicine to better inform their treatment planning for their patients.”
“The medical doctors and scientists at CollabRx have created this breakthrough tool, and MedPage Today has the strongest platform to reach physicians and help change cancer patient outcomes,” said James Karis, CEO of CollabRx.
About MedPage Today
MedPage Today is the fastest growing news organization serving healthcare professionals (comScore). The company’s daily, peer-reviewed news coverage delivered via the web and several mobile applications allows healthcare professionals to put breaking medical news into practice. MedPage Today also offers coverage of health conferences from around the world in almost any specialty, and physicians can access live video interviews and dialogues to encourage conversation and better health outcomes.
About Everyday Health, Inc.
Everyday Health is the leading new media health company. Attracting 38 million people monthly through its popular websites, mobile applications, and social media presence, Everyday Health inspires consumers to live healthier lives and helps doctors make more informed decisions for their patients. Everyday Health reaches an additional one million viewers per episode through its weekly TV series on ABC stations. The Company’s broad portfolio of products spans the health spectrum, from in-depth medical content for condition prevention and management to healthy lifestyle offerings. Everyday Health was founded in 2002 by CEO, Ben Wolin, and President, Mike Keriakos. Source: comScore Media Metrix; comScore Video Metrix; Facebook Insights; Twitter
CollabRx is a recognized leader in “cloud-based” expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world’s knowledge on genomics-based medicine with specific insights from the nation’s top medical and scientific experts, starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. For more information, visit http://www.collabrx.com.
Contact: Everyday Health, Inc.: Jennifer Perciballi, Vice President, Public Relations, 646.728.9777 office, 646.476.1245 mobile, email@example.com